SCHEMBL22117358

SCHEMBL22117358

N#[N+]c1ccc(N2C(=O)C=CC2=O)cc1

nearest known ligand 0.68

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ MGLL Q99685 16/20 0.68
▸ FAAH O00519 6/20 0.68
▸ HSP90AA1 P07900 3/20 0.56
▸ TDP1 Q9NUW8 2/20 0.56
▸ PKM P14618 1/20 0.56
▸ MAPK1 P28482 1/20 0.56
▸ NPSR1 Q6W5P4 1/20 0.56
▸ BCHE P06276 1/20 0.50
▸ DDAH1 O94760 1/20 0.50
▸ ALDH1A1 P00352 1/20 0.48
▸ LMNA P02545 1/20 0.48
▸ CCR6 P51684 1/20 0.48
▸ CACNA1B Q00975 1/20 0.48
▸ APBA1 Q02410 1/20 0.48
▸ APOBEC3G Q9HC16 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL95324 0.83 MGLL (1.00) MGLLFAAHHSP90AA1TDP1PKM
SCHEMBL21630074 0.75 MGLL (0.83) MGLLFAAHHSP90AA1TDP1PKM
SCHEMBL1321309 0.75 MGLL (0.83) MGLLFAAHHSP90AA1TDP1PKM
SCHEMBL19511560 0.75 MGLL (0.83) MGLLFAAHHSP90AA1TDP1PKM
SCHEMBL9839165 0.73 MGLL (0.79) MGLLFAAHHSP90AA1TDP1PKM
SCHEMBL10668708 0.71 MGLL (0.75) MGLLFAAHHSP90AA1TDP1PKM
SCHEMBL284697 0.71 MGLL (0.75) MGLLFAAHHSP90AA1TDP1PKM
SCHEMBL962950 0.71 MGLL (1.00) MGLLFAAHHSP90AA1TDP1PKM
SCHEMBL140288 0.71 MGLL (1.00) MGLLFAAHHSP90AA1TDP1PKM
SCHEMBL140025 0.71 MGLL (1.00) MGLLFAAHHSP90AA1TDP1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12111313-B2 Chelator-coated field effect transistor and devices and methods using same Autonomous Medical Devices Inc. (US) 2024-10-08 — — US disclosed
US-20210310044-A1 ANTIBODY OR APTAMER CONJUGATED-POLYNUCLEOTIDES AND DETECTION METHODS AND MICROFLUIDICS DEVICES USING THE SAME Autonomous Medical Devices Inc. (US) 2021-10-07 — — US disclosed
US-20210311028-A1 ANTIBODY OR APTAMER CONJUGATED-LIPID VESICLES AND DETECTION METHODS AND MICROFLUIDICS DEVICES USING SAME Autonomous Medical Devices Inc. (US) 2021-10-07 — — US disclosed
US-20210293798-A1 Chelator-Coated Field Effect Transistor and Devices and Methods Using Same Autonomous Medical Devices Inc. (US) 2021-09-23 — — US disclosed
EP-3864412-A1 ANTIBODY OR APTAMER CONJUGATED-POLYNUCLEOTIDES AND DETECTION METHODS AND MICROFLUIDICS DEVICES USING THE SAME Sensor-Kinesis Corporation (US) 2021-08-18 — — EP disclosed
EP-3864411-A1 ANTIBODY OR APTAMER CONJUGATED-LIPID VESICLES AND DETECTION METHODS AND MICROFLUIDICS DEVICES USING SAME Sensor-Kinesis Corporation (US) 2021-08-18 — — EP disclosed
WO-2020077304-A9 ANTIBODY OR APTAMER CONJUGATED-LIPID VESICLES AND DETECTION METHODS AND MICROFLUIDICS DEVICES USING SAME Sensor-Kinesis Corporation (US) 2020-06-25 — — WO disclosed
CN-1063109-A Improvement to hormone and associated materials PROTEUS MOLECULAR DESIGN (GB) 1992-07-29 — — CN disclosed
Send feedback